Technical Analysis for BBC - Virtus LifeSci Biotech Clinical Trials ETF
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 26.17 | -0.67% | -0.18 |
BBC closed down 0.67 percent on Wednesday, November 20, 2024, on 1.33 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 180 Bearish Setup | Bearish Swing Setup | 0.00% | |
| Stochastic Buy Signal | Bullish | 0.00% | |
| Calm After Storm | Range Contraction | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Calm After Storm | Range Contraction | -0.67% | |
| Lower Bollinger Band Walk | Weakness | -0.67% | |
| Lower Bollinger Band Touch | Weakness | -0.67% |
| Alert | Time |
|---|---|
| Rose Above Lower Bollinger Band | 1 day ago |
| 2x Volume Pace | 1 day ago |
| 1.5x Volume Pace | 1 day ago |
| Fell Below Previous Day's Low | 1 day ago |
| Down 1% | 1 day ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.
Keywords: Biotechnology Health Sciences Drug Discovery Pharmacology Clinical Research Clinical Trial
Classification
Keywords: Biotechnology Health Sciences Drug Discovery Pharmacology Clinical Research Clinical Trial
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Date | Title |
|---|---|
| Oct 31 | F/m Guides Emerald Advisers’ ETF Debut |
| Indicator | Value |
|---|---|
| 52 Week High | 31.99 |
| 52 Week Low | 18.7033 |
| Average Volume | 1,790 |
| 200-Day Moving Average | 27.79 |
| 50-Day Moving Average | 28.74 |
| 20-Day Moving Average | 28.95 |
| 10-Day Moving Average | 28.57 |
| Average True Range | 0.72 |
| RSI (14) | 32.43 |
| ADX | 20.63 |
| +DI | 22.14 |
| -DI | 52.24 |
| Chandelier Exit (Long, 3 ATRs) | 29.50 |
| Chandelier Exit (Short, 3 ATRs) | 27.96 |
| Upper Bollinger Bands | 32.04 |
| Lower Bollinger Band | 25.87 |
| Percent B (%b) | 0.05 |
| BandWidth | 21.31 |
| MACD Line | -0.58 |
| MACD Signal Line | -0.07 |
| MACD Histogram | -0.5132 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 26.44 | ||||
| Resistance 3 (R3) | 26.47 | 26.41 | 26.39 | ||
| Resistance 2 (R2) | 26.41 | 26.34 | 26.39 | 26.38 | |
| Resistance 1 (R1) | 26.29 | 26.29 | 26.26 | 26.26 | 26.36 |
| Pivot Point | 26.23 | 26.23 | 26.21 | 26.21 | 26.23 |
| Support 1 (S1) | 26.11 | 26.16 | 26.08 | 26.08 | 25.97 |
| Support 2 (S2) | 26.05 | 26.11 | 26.03 | 25.96 | |
| Support 3 (S3) | 25.93 | 26.05 | 25.94 | ||
| Support 4 (S4) | 25.90 |
